CannaPharmaRx Inc

OTC • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 11/06/2026 10:36

Company Profile

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

ExchangeOTC

Market Capitalization1.42 mln

Float662 mln

Earnings Date11/13/2026

Piotroski F-Score

3 / 9

Below average

Beneish M-Score

-10.9

Highly reliable

Relative Strength

9 / 100

Severely lagging

Pre-Tax Margin

-666%

Severely loss-making

ROE

39.79

Very strong

Altman Z-Score

-32.62

Deeply distressed

Business Description

CannaPharmaRX Inc. grows and sells medical cannabis across four countries: Germany, Israel, Portugal, and Canada. The company offers a range of products, from dried flower to specialty strains developed through careful breeding. It operates out of Cremona, Canada.

Key Fundamentals

EPS-0.01

ROE39.79

RPS0.00

ROIC-10.36

ROA-130

Interest Cover-1.19

EBITDA, mln-8.67

EV / EBITDA-2.61

EV / EBIT-2.60

Revenue, mln1.70

EV / Revenue13.31

Quote Details

Last 0.002

Change 0.0005 (33.33%)

Open 0.0012

Volume 802,000

Turnover 1,604

Average Volume 245,180

Financial Ratios

Pre-Tax Profit Margin-666

Current Ratio0.04

Price / Cash Flow5.28

Price / Free Cash Flow2.00

Price / Sales1.00

Financial Strength

Altman Z-Score-32.62

Piotroski F-Score 3 / 9

Beneish M-Score-10.9

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	0%	5 / 100
1 Month	0%	18 / 100
2 Months	-16.67%	18 / 100
6 Months	-59.18%	9 / 100
1 Year	-37.5%	20 / 100